SCHEMBL1300630

SCHEMBL1300630

C1=C2CCCNCN2CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15526123 0.78 USP2 (0.40)
SCHEMBL483180 0.78
SCHEMBL389739 0.77
Hydrochloric Acid SCHEMBL29689430 0.76
SCHEMBL368150 0.74 MAPT (0.37)
SCHEMBL860227 0.74 HRH1 (0.41)
SCHEMBL15310285 0.74 TDP1 (0.36)
SCHEMBL1327604 0.74
SCHEMBL10437043 0.73 SMN1; SMN2 (0.43)
SCHEMBL2795198 0.73 MAPT (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040068107-A1 Method for the production of pentopyranosly nucleosides KRETSCHMAR GERHARD (DE) 2004-04-08 US claimed
CN-107721958-B Novel compounds and compositions for targeting cancer stem cells 北京强新生物科技有限公司 2024-08-23 CN disclosed
EP-2547205-B1 NOVEL METHODS FOR TARGETING CANCER STEM CELLS 1GLOBE BIOMEDICAL CO LTD (CN) 2024-03-20 EP disclosed
CN-107375260-B Novel compounds and compositions for targeting cancer stem cells 北京强新生物科技有限公司 2023-10-24 CN disclosed
CN-107311969-B Novel compounds and compositions for targeting cancer stem cells 北京强新生物科技有限公司 2022-01-28 CN disclosed
US-20200397740-A1 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER Sumitomo Dainnipon Pharma Oncology. Inc. (US) 2020-12-24 US disclosed
US-10543189-B2 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer BOSTON BIOMEDICAL, INC. (US) 2020-01-28 US disclosed
US-20180193303-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS BOSTON BIOMEDICAL INC (US) 2018-07-12 US disclosed
EP-3108750-B1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS 1GLOBE BIOMEDICAL CO LTD (CN) 2018-07-04 EP disclosed
EP-3295796-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS 1Globe Biomedical Co., Ltd. (CN) 2018-03-21 EP disclosed
US-4822788-A MICROBIOCIDES, BETA-LACTAMASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-04-18 US disclosed
US-4782147-A ANTIBIOTIC TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1988-11-01 US disclosed
EP-0053816-B1 1-SULFO-2-OXOAZETIDINE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1988-05-04 EP disclosed
US-4675397-A MICROBIOCIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-06-23 US disclosed
US-4665067-A BACTERICIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-05-12 US disclosed
US-4550105-A BETA-LACTAMASE INHIBITORS, ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1985-10-29 US disclosed
EP-0093376-A2 1-Sulfo-2-azetidinone derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1983-11-09 EP disclosed
EP-0053816-A1 1-Sulfo-2-oxoazetidine derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1982-06-16 EP disclosed
US-4238391-A AMIDATION OF BLEOMYCINIC ACID NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1980-12-09 US disclosed
US-4195018-A CARCINOSTATIC ANTIBIOTICS NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1980-03-25 US disclosed